Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uma Mahadevan

Showing results (141-150 of 173) with videos related to

Pageof 18
Sort By:
Inflammatory Bowel Diseases|July 9, 2018
Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative ColitisUma Mahadevan, Marla C Dubinsky, Chinyu Su, et al.
Diseases of the Colon and Rectum|July 22, 2020
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn's DiseaseAmy L Lightner, Jon D Vogel, Joseph C Carmichael, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2012
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel diseaseUma Mahadevan, Douglas C Wolf, Marla Dubinsky, et al.
Gastroenterology|January 13, 2010
Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitisWilliam J Sandborn, Joshua Korzenik, Bret Lashner, et al.
Journal of the Pediatric Infectious Diseases Society|March 26, 2016
Vertical Transmission of Histoplasmosis Associated With Anti-Tumor Necrosis Factor TherapyJames G Carlucci, Natasha Halasa, C Buddy Creech, et al.
Drug Safety|July 15, 2024
Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing ReportsUma Mahadevan, Gweneth Levy, Lianne Gensler, et al.
Intestinal Research|May 19, 2026
Real-world use and perceptions of advanced combined therapies in treating inflammatory bowel diseaseHsin-Yun Wu, Zhi-Che Chen, Meng-Tzu Weng, et al.
Diseases of the Colon and Rectum|April 14, 2021
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Ulcerative ColitisStefan D Holubar, Amy L Lightner, Vitaliy Poylin, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Single-cell spatial transcriptomics of fixed, paraffin-embedded biopsies reveals colitis-associated cell networksElvira Mennillo, Madison L Lotstein, Gyehyun Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 28, 2025
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel DiseaseUma Mahadevan, Cynthia H Seow, Edward L Barnes, et al.
Pageof 18

Showing results (141-150 of 173) with videos related to

Sort By:
Pageof 18
Inflammatory Bowel Diseases|July 9, 2018
Outcomes of Pregnancies With Maternal/Paternal Exposure in the Tofacitinib Safety Databases for Ulcerative ColitisUma Mahadevan, Marla C Dubinsky, Chinyu Su, et al.
Diseases of the Colon and Rectum|July 22, 2020
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Crohn's DiseaseAmy L Lightner, Jon D Vogel, Joseph C Carmichael, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2012
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel diseaseUma Mahadevan, Douglas C Wolf, Marla Dubinsky, et al.
Gastroenterology|January 13, 2010
Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitisWilliam J Sandborn, Joshua Korzenik, Bret Lashner, et al.
Journal of the Pediatric Infectious Diseases Society|March 26, 2016
Vertical Transmission of Histoplasmosis Associated With Anti-Tumor Necrosis Factor TherapyJames G Carlucci, Natasha Halasa, C Buddy Creech, et al.
Drug Safety|July 15, 2024
Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing ReportsUma Mahadevan, Gweneth Levy, Lianne Gensler, et al.
Intestinal Research|May 19, 2026
Real-world use and perceptions of advanced combined therapies in treating inflammatory bowel diseaseHsin-Yun Wu, Zhi-Che Chen, Meng-Tzu Weng, et al.
Diseases of the Colon and Rectum|April 14, 2021
The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for the Surgical Management of Ulcerative ColitisStefan D Holubar, Amy L Lightner, Vitaliy Poylin, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Single-cell spatial transcriptomics of fixed, paraffin-embedded biopsies reveals colitis-associated cell networksElvira Mennillo, Madison L Lotstein, Gyehyun Lee, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 28, 2025
Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel DiseaseUma Mahadevan, Cynthia H Seow, Edward L Barnes, et al.
Pageof 18